To maximise the cardiovascular benefits of GLP-1 RAs at a population level, strategies can be used to improve tolerability, such as patient counselling, gradual dose escalation and the use of long-acting formulations [27]
Talk about this with your clinician, though, as recent studies havent shown that same link
By emitting a do not eat me signal, CD47 inhibits the phagocytic capacity of microglia toward both ferroptotic neurons and A plaques, leading to an immune-tolerant state
But in the Gila monsters saliva, theres a version of this hormone called exendin-4
Step 6: Monitor and adjust Review progress at 4-week intervals
Its unlikely to become available to patients until 2027 at the soonest